Publikationen, an denen er mitarbeitet FRANCISCO JAVIER O'VALLE RAVASSA (20)

2023

  1. Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats

    Biomedicine and Pharmacotherapy, Vol. 158

  2. Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study

    Gut Microbes, Vol. 15, Núm. 2

2021

  1. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus

    British Journal of Pharmacology, Vol. 178, Núm. 18, pp. 3708-3729

  2. Gut microbiota has a crucial role in the development of hypertension and vascular dysfunction in toll-like receptor 7-driven lupus autoimmunity

    Antioxidants, Vol. 10, Núm. 9

2020

  1. Lactobacillus fermentum CECT5716 prevents renal damage in the NZBWF1 mouse model of systemic lupus erythematosus

    Food & function, Vol. 11, Núm. 6, pp. 5266-5274

  2. Toll-like receptor 7-driven lupus autoimmunity induces hypertension and vascular alterations in mice

    Journal of hypertension, Vol. 38, Núm. 7, pp. 1322-1335

2019

  1. Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus

    FASEB Journal, Vol. 33, Núm. 9, pp. 10005-10018

2017

  1. Activation of Peroxisome Proliferator Activator Receptor β/δ Improves Endothelial Dysfunction and Protects Kidney in Murine Lupus

    Hypertension, Vol. 69, Núm. 4, pp. 641-650

  2. Glutamyl aminopeptidase in microvesicular and exosomal fractions of urine is related with renal dysfunction in cisplatin-treated rats

    PLoS ONE, Vol. 12, Núm. 4

2014

  1. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus

    Hypertension, Vol. 64, Núm. 2, pp. 330-337

2013

  1. Influence of thyroid state on cardiac and renal capillary density and glomerular morphology in rats

    Journal of Endocrinology, Vol. 216, Núm. 1, pp. 43-51

2011

  1. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats

    British Journal of Nutrition, Vol. 106, Núm. 9, pp. 1337-1348

  2. Red wine polyphenols prevent endothelial dysfunction induced by endothelin-1 in rat aorta: Role of NADPH oxidase

    Clinical Science, Vol. 120, Núm. 8, pp. 321-333

2009

  1. Quercetin inhibits vascular superoxide production induced by endothelin-1: Role of NADPH oxidase, uncoupled eNOS and PKC

    Atherosclerosis, Vol. 202, Núm. 1, pp. 58-67

2008

  1. Wine polyphenols improve endothelial function in large vessels of female spontaneously hypertensive rats

    Hypertension, Vol. 51, Núm. 4 PART 2 SUPPL., pp. 1088-1095

2007

  1. Polyphenols restore endothelial function in DOCA-salt hypertension: Role of endothelin-1 and NADPH oxidase

    Free Radical Biology and Medicine, Vol. 43, Núm. 3, pp. 462-473

2005

  1. Endothelial nitric oxide production stimulated by the bioflavonoid chrysin in rat isolated aorta

    Planta Medica, Vol. 71, Núm. 9, pp. 829-834

2004

  1. Effects of the dietary flavonoid chrysin in isolated rat mesenteric vascular bed

    Journal of Vascular Research, Vol. 41, Núm. 6, pp. 509-516

  2. Protective effects of the angiotensin II type I (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats

    Clinical Science, Vol. 106, Núm. 3, pp. 251-259

2002

  1. Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats

    Journal of Hypertension, Vol. 20, Núm. 9, pp. 1843-1854